For the 25 million Americans living with asthma, the fear of experiencing an attack without quick access to medication is all too real. While rescue inhalers remain the gold standard for treating ...
An asthma attack is much more than just feeling winded after exercise and needing to catch your breath. Asthma is a chronic condition that affects 25 million people in the U.S. and involves the ...
An asthma attack makes breathing hard, and it can be triggered by allergens or intense emotions. It is important to use a ...
Asthma can be a real challenge, right? Whether it is wheezing, coughing, or shortness of breath, these symptoms can make daily life harder than it needs to be. If you or someone you love suffers from ...
An asthma attack is a sudden worsening of asthma symptoms caused by inflammation and a narrowing of the airways. This can make breathing difficult and, in severe cases, be life-threatening. Asthma ...
Asthma is the most common airway disease, affecting nearly 25 million Americans, according to the Centers for Disease Control and Prevention. Symptom flares, called "asthma attacks," are not ...
HENRY COUNTY, Ga. — A Metro Atlanta family is fighting for justice. Their son was having an asthma attack and they called for ...
Blood eosinophil count and fractional exhaled nitric oxide (FeNO) play an important role in selecting biological therapies for severe asthma. This analysis of patient-level data pooled across 22 ...
Cole Schmidtknecht expected to pay $66.86 for a three-month supply of his preventative asthma inhalers in January 2024 when he went to his Walgreens pharmacy in Appleton, Wisconsin. The pharmacy ...
Most people with asthma are able to control their symptoms by using inhaled medicines each day. But for some people with severe asthma, inhaled medicines are not enough to keep symptoms under control.
Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.
A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, cutting attacks by ...